 Emmaus Life Sciences Inc said it has received its first major purchase order from its distributor in the Kingdom of Saudi Arabia, where its drug Endari is available on an early access basis. The Torrance, California-based company said it also has been issued a registration certificate from the Qatar Ministry of Public Health granting marketing authorization for the commercial distribution and sale of Endari in the country. 